Obstetrics and Gynecology International / 2016 / Article / Tab 2

Research Article

Knowledge of Latin American Obstetricians and Gynecologists regarding Heavy Menstrual Bleeding

Table 2

Answers provided by the OBGYNs regarding some therapeutic aspects of heavy menstrual bleeding (HMB).

Age (%)Gender (%)Working in (%)
≤49 ys≥50 ysFemale MalePublic sectorPrivate/public sector

What is the proportion of women with improvement of HMB with a COC with EE? (n = 203)
<50% 98.079.487.189.786.790.0
Up to 80%2.020.612.910.313.310.0
What is the proportion of women with improvement of HMB with a COC with estradiol Val/DNG? (n = 199)
30–40%27.739.027.837.738.829.3
41–79%41.228.428.335.232.333.6
>80%31.132.643.927.128.937.1
What is the proportion of women with improvement of HMB with an LNG-IUS at the end of the first year of use? (n = 201)
30–79%75.675.682.970.281.671.7
>80%24.424.417.129.818.428.3

OBGYNs: obstetricians and gynecologists; COC: combined oral contraceptive; EE: ethynyl estradiol; LNG-IUS: levonorgestrel-releasing intrauterine system.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.